This could be a completely silly question so apologies in advance, but given that a number of responding ME patients treated with Rituximab report improvements followed by relapse when their B cells come back, are there any drugs out there that could:
- Suppress circulating B cells to a point where clinical improvement is seen.
- Disrupt B cell signalling somehow.
- Do something else to B cells that might benefit us.
